[A case of advanced non-small-cell lung cancer responding remarkably to weekly chemotherapy with paclitaxel].
We report a case of advanced non-small-cell lung cancer showing remarkable response to weekly administration of paclitaxel. The patient was a 63-year-old man who had IIIB advanced lung adenocarcinoma. Though he received one course of cisplatin and etoposide, the tumor was not reduced. In addition, because of his nauseous response, he no longer wanted to receive that chemotherapy. The chemotherapy regimen was therefore changed to weekly administration of vinorelbine, but this was not effective. Next, after changing the regimen to the weekly administration of paclitaxel, the tumor was remarkably reduced following 3 courses. This case shows that weekly administration of paclitaxel may be an effective chemotherapy for non-small cell lung cancer not responsive to first-line chemotherapy.
Kato
K
K
Dept. of Internal Medicine, Matsue National Hospital.
Kawasaki
Y
Y
Yano
S
S
Miyata
M
M
Mikami
M
M
Yasuda
K
K
Hitsuda
Y
Y
Shimizu
E
E
D000230:Adenocarcinoma / Q000000981:diagnostic imaging / Q000188:drug therapy*; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage*; D002289:Carcinoma, Non-Small-Cell Lung / Q000000981:diagnostic imaging / Q000188:drug therapy*; D004334:Drug Administration Schedule; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D017239:Paclitaxel / Q000008:administration & dosage*; D011859:Radiography
D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel